Chief Operating Officer
Stuart R. Gallant, MD, PhD
Dr. Gallant is a pharmaceutical industry professional with a broad range of manufacturing, process development, and drug delivery experience. He is an expert on virus and cell-based product manufacturing with experience in Adenovirus and Adeno-Associated Virus manufacture, as well as in cell-based cancer vaccine manufacture.
He has worked on the full range of clinical stages from early development to late stage and commercial products, as well as the full range of markets from orphan products to a multibillion dollar commercial blockbuster. Dr. Gallant is particularly familiar with lean and virtual manufacturing strategies. He started his career at Bayer, leading projects at Bayer’s Berkeley, California site. And, he went on to lead process development or manufacturing functions at Biomarin, Coherus, and Anthera.
Dr. Gallant holds a PhD in Chemical Engineering from Rensselaer Polytechnic Institute and an MD from the University of California Davis. He has numerous peer-reviewed articles, book chapters, and corporate technical reports. He is active in the ISPE, AIChE, and ACS.